Albemarle (ALB) Expected to Release Earnings on Wednesday

Albemarle (NYSE:ALB) is anticipated to announce its Q3 2026 results after the market closes on Wednesday, November 4th. Analysts expect the company to announce earnings of $2.53 per share and revenue of $1.52 billion for the quarter. Individuals are encouraged to explore the company’s upcoming Q3 2026 earnings overview page for the latest details on the call scheduled for Thursday, November 5, 2026 at 8:00 AM ET.

Albemarle (NYSE:ALB) last released its earnings results on Wednesday, August 5th. The specialty chemicals company reported $3.75 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.20 by $0.55. Albemarle had a net margin of 3.09% and a return on equity of 10.96%. The firm had revenue of $1.74 billion during the quarter, compared to analyst estimates of $1.61 billion. During the same quarter last year, the business earned $0.11 EPS. The business’s revenue was up 31.1% on a year-over-year basis. On average, analysts expect Albemarle to post $11.15 EPS for the current fiscal year and $11.22 EPS for the next fiscal year.

Albemarle Stock Performance

Albemarle stock opened at $91.00 on Monday. The company has a debt-to-equity ratio of 0.22, a current ratio of 2.09 and a quick ratio of 1.35. The company’s 50-day moving average is $111.88 and its 200 day moving average is $149.82. Albemarle has a 1-year low of $88.01 and a 1-year high of $221.00. The firm has a market capitalization of $10.74 billion, a P/E ratio of 337.05, a price-to-earnings-growth ratio of 0.54 and a beta of 1.34.

Albemarle Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, January 4th. Stockholders of record on Friday, December 18th will be given a dividend of $0.41 per share. This represents a $1.64 annualized dividend and a dividend yield of 1.8%. The ex-dividend date is Friday, December 18th. Albemarle’s dividend payout ratio (DPR) is 607.41%.

Wall Street Analyst Weigh In

A number of brokerages recently weighed in on ALB. Morgan Stanley reiterated a “reduce” rating and set a $161.00 price objective on shares of Albemarle in a report on Monday, August 10th. JPMorgan Chase & Co. decreased their price target on shares of Albemarle from $160.00 to $140.00 and set a “neutral” rating for the company in a research report on Tuesday, August 25th. Weiss Ratings downgraded Albemarle from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Friday, October 23rd. Argus cut their price target on shares of Albemarle from $230.00 to $135.00 and set a “buy” rating on the stock in a research note on Wednesday, October 7th. Finally, Scotiabank reduced their price objective on Albemarle from $200.00 to $190.00 and set a “sector outperform” rating for the company in a research note on Monday, August 10th. Fifteen research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and three have issued a Sell rating to the company. According to MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $179.41.

About Albemarle

Albemarle Corporation (NYSE: ALB) is a global specialty chemicals company headquartered in Charlotte, North Carolina. The company develops, manufactures, and markets engineered chemicals used in energy storage, transportation, refining, pharmaceuticals, agriculture, consumer products, and other industrial applications.

Albemarle is one of the world’s major producers of lithium and supplies lithium compounds, including lithium carbonate and lithium hydroxide, for use in rechargeable batteries for electric vehicles, portable electronics, and grid energy-storage systems.